CHINYERE OSUCHUKWU: Open Payments
NPI 1346773983 · PORTSMOUTH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 11 payments from 6 companies in 2025. Trend: 2023 $123 · 2024 $324 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $71 |
| Fresenius USA Marketing, Inc. | 3 | $54 |
| Aurinia Pharma U.S., Inc. | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Calliditas Therapeutics US Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $14 |
Products named: IBSRELA, VELPHORO, LUPKYNIS, JARDIANCE, TARPEYO, Ozempic.
Industry payments across VA — which companies pay providers there.
